Get started
Author

Corina Cornila

Observed names: C Cornila, C. Cornila, CORINA CORNILA
ORCID: 0009-0008-0765-9904
Observed ORCID: 0009-0008-0765-9904
OpenAlex ID: A5020851341
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials
2018 · Thomas Aparicio, Michel Ducreux, et al. · European Journal of Cancer · 46
PDF
Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial
2024 · Isabelle L. Ray-Coquard, Aude-Marie Savoye, et al. · Nature Communications · 33
Efficacy and safety results from neopembrov study, a randomized phase II trial of neoadjuvant chemotherapy (CT) with or without pembrolizumab (P) followed by interval debulking surgery and standard systemic therapy ± P for advanced high-grade serous carcinoma (HGSC): A GINECO study.
2021 · Isabelle Laure Ray-Coquard, Aude Marie Savoye, et al. · Journal of Clinical Oncology · 13
Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study
2023 · HELOÏSE BOURIEN, LEÏLA BENGRINE LEFEVRE, et al. · Anticancer Research · 7
PDF
Multicentre randomized phase II trial of olaparib as maintenance therapy in platinum-sensitive advanced endometrial carcinoma: The GINECO-UTOLA study.
2020 · Florence Joly, Pierre Emmanuel Brachet, et al. · Journal of Clinical Oncology · 4
ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al. · Clinical Cancer Research · 2
ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial
2026 · Félix Blanc-Durand, Catherine Genestie, et al. · Clinical Cancer Research · 2
2022-RA-922-ESGO Histo-molecular characteristics of platinum-sensitive advanced endometrial cancer: data issued from the population included in the GINECO UTOLA study
2022 · Florence Joly, Pierre Alexandre Just, et al. · International Journal of Gynecological Cancer · 2
PDF
260 Impact of BRCA & PD-L1 in EOC patients receiving standard 1st line therapy +/- Pembrolizumab: Exploratory analyses from the NeoPembrOV Study (GINECO)
2021 · O. Le Saux, A.M. Savoye, et al. · International Journal of Gynecological Cancer · 2
PDF
Split course radiation with concurrent vinorelbine and cisplatin in locally advanced non-small cell lung cancer. A phase II study.
2004 · M Dediu, A Tarlea, et al. · PubMed · 2
823P Extended follow-up of a real-world cohort of patients (pts) with BRCA mutation (BRCAm) relapsed epithelial ovarian cancer (EOC) receiving olaparib maintenance therapy: The GINECO RETROLA study
2020 · T. de La Motte Rouge, L. Bengrine Lefevre, et al. · Annals of Oncology · 1
Supplementary Table S1 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al.
Supplementary Figure S3 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al.
Supplementary Figure S2 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al.
Supplementary Figure S8 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al.
Supplementary Figure S6 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al.
Supplementary Figure S7 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al.
Supplementary Figure S1 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al.
Supplementary Figure S5 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al.
Supplementary Figure S4 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al.
Data from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al.
Supplementary Figure S9 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
2026 · Guillaume Beinse, Valerie Taly, et al.
Data from ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial
2026 · Félix Blanc-Durand, Catherine Genestie, et al.
Supplementary Table S1 from ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial
2026 · Félix Blanc-Durand, Catherine Genestie, et al.
Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial
2025 · Guillaume Beinse, Karen Leroy, et al. · International Journal of Gynecological Cancer
Works count: 29
Citation count: 114
H-index: 4
I10-index: 3
Year
Topic
Type